Teng F - Search Results

1

MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.

Bao L, Zhang M, Han S, Zhan Y, Guo W, Teng F, Liu F, Guo M, Zhang L, Ding G, Wang Q. Bao L, et al. Among authors: teng f. Cell Physiol Biochem. 2018;47(5):2046-2055. doi: 10.1159/000491472. Epub 2018 Jul 3. Cell Physiol Biochem. 2018. PMID: 29969781 Free article.

2

MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1.

Zhan Y, Zheng N, Teng F, Bao L, Liu F, Zhang M, Guo M, Guo W, Ding G, Wang Q. Zhan Y, et al. Among authors: teng f. Oncotarget. 2017 May 22;8(40):67169-67180. doi: 10.18632/oncotarget.18052. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978024 Free PMC article.

3

lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.

Dong J, Teng F, Guo W, Yang J, Ding G, Fu Z. Dong J, et al. Among authors: teng f. Cell Physiol Biochem. 2018;51(5):2262-2274. doi: 10.1159/000495871. Epub 2018 Dec 7. Cell Physiol Biochem. 2018. PMID: 30537734 Free article.

4

A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.

Wang ZX, Song SH, Teng F, Wang GH, Guo WY, Shi XM, Ma J, Wu YM, Ding GS, Fu ZR. Wang ZX, et al. Among authors: teng f. Clin Transplant. 2010 Nov-Dec;24(6):752-7. doi: 10.1111/j.1399-0012.2009.01172.x. Clin Transplant. 2010. PMID: 20030683 Clinical Trial.

5

Prognostic model for patients receiving arterial-embolization for hepatocellular carcinoma: issues to consider.

Liu B, Teng F, Ding G. Liu B, et al. Among authors: teng f. Liver Int. 2016 Feb;36(2):311. doi: 10.1111/liv.12892. Epub 2015 Sep 18. Liver Int. 2016. PMID: 26096771 No abstract available.

6

Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.

Teng F, Han QC, Ding GS, Ni ZJ, Fu H, Guo WY, Shi XM, Gao XG, Ma J, Fu ZR. Teng F, et al. Sci Rep. 2015 Jun 22;5:11733. doi: 10.1038/srep11733. Sci Rep. 2015. PMID: 26096817 Free PMC article.

7

Favorable effect of thrombocytopenia on outcomes of liver transplantation for hepatocellular carcinoma.

Liu B, Liu K, Teng F, Fu H, Guo WY, Shi XM, Ni ZJ, Gao XG, Ma J, Fu ZR, Ding GS. Liu B, et al. Among authors: teng f. Scand J Gastroenterol. 2016;51(4):509-10. doi: 10.3109/00365521.2015.1095940. Scand J Gastroenterol. 2016. PMID: 26784975 No abstract available.

8

Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas.

Teng F, Guo M, Liu F, Wang C, Dong J, Zhang L, Zou Y, Chen R, Sun K, Fu H, Fu Z, Guo W, Ding G. Teng F, et al. Oncotarget. 2016 Aug 16;7(33):53571-53582. doi: 10.18632/oncotarget.10670. Oncotarget. 2016. PMID: 27447551 Free PMC article.

9

Immunometabolic inflammation and hepatocellular carcinoma.

Mao JX, Teng F, Liu C, Yuan H, Dong JY, Fu H, Ding GS, Guo WY. Mao JX, et al. Among authors: teng f. Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):298-300. doi: 10.1016/j.hbpd.2019.03.012. Epub 2019 Apr 17. Hepatobiliary Pancreat Dis Int. 2019. PMID: 31027911 No abstract available.

10

Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients.

Mao JX, Guo WY, Guo M, Liu C, Teng F, Ding GS. Mao JX, et al. Among authors: teng f. Hepatol Int. 2020 May;14(3):347-361. doi: 10.1007/s12072-020-10022-4. Epub 2020 Mar 5. Hepatol Int. 2020. PMID: 32140981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,042 results

Search Page

Filters